TB-500 Fragment 10mg

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of TB-500 Fragment supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety.

Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques.

Batch: GF082025010

Key analytical results include:

• Assay Content: 9.66 mg
• Identification – Retention Time: 0.993
• Identification – Spectrum: 998
• Purity: greater than 99.8 percent
• Bacterial Endotoxins: below 0.001 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium.

These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency.

Product Overview

TB-500 Fragment is a synthetic peptide research compound derived from a functional segment of the Thymosin Beta-4 protein. It is frequently studied in controlled laboratory environments investigating peptide-mediated cellular signalling and regulatory pathways.

The peptide belongs to a class of actin-interacting peptide fragments involved in cellular structure regulation and intracellular signalling dynamics.

This preparation contains 10 mg of high purity lyophilized peptide supplied in a sealed research vial. The lyophilization process preserves peptide stability and allows researchers to reconstitute the compound for controlled in vitro experimentation.

Because of its defined peptide fragment structure and stable analytical profile, TB-500 Fragment has become a commonly referenced compound in experimental peptide signalling and cellular regulation research models.

Compound Overview

TB-500 Fragment is a synthetic peptide fragment derived from the larger Thymosin Beta-4 protein, which is naturally present in various mammalian tissues.

Thymosin Beta-4 and its peptide fragments interact with actin, a key structural protein involved in cytoskeletal organization, cellular movement and intracellular transport.

Research involving TB-500 Fragment frequently explores peptide-mediated cellular migration pathways, cytoskeletal regulation and intracellular signalling networks.

Due to its defined peptide fragment structure, TB-500 Fragment is widely utilised in laboratory research investigating molecular regulatory processes and peptide signalling dynamics.

Historical Background and Scientific Context

Scientific interest in thymosin peptides began during the late twentieth century when researchers identified a family of small proteins involved in cellular regulation and immune system processes.

Further biochemical investigation revealed that fragments of Thymosin Beta-4 interact with actin-binding mechanisms that influence cytoskeletal organization and cellular signalling.

As peptide synthesis technology advanced, synthetic fragments such as TB-500 Fragment were developed to allow researchers to study these molecular mechanisms in controlled laboratory settings.

Since then, peptide fragments derived from Thymosin Beta-4 have been widely used in experimental research investigating intracellular signalling and peptide regulatory pathways.

Mechanistic Focus in Research

Within experimental laboratory settings, TB-500 Fragment is commonly studied in relation to actin interaction pathways and cellular regulatory signalling mechanisms.

Research investigations commonly explore the compound in experimental models examining:

• Actin-binding protein interactions
• Cellular migration signalling pathways
• Cytoskeletal organization processes
• Peptide-mediated intracellular signalling networks
• Comparative peptide interaction research
• Molecular regulatory pathway modelling
• Cellular structural protein dynamics

These experimental models allow scientists to investigate molecular mechanisms that regulate cellular structure, movement and biochemical signalling processes.

Research Applications

In controlled research environments, TB-500 Fragment may be utilised in experimental models designed to explore peptide-mediated cellular regulatory systems.

Examples of research applications include:

• Cell migration research models
• Cytoskeletal regulation studies
• Actin-binding protein interaction analysis
• Molecular signalling pathway investigation
• Comparative peptide compound evaluation
• Intracellular regulatory network modelling
• Controlled in vitro peptide studies

Grail Formula Quality

Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation.

Each batch undergoes independent analytical testing to verify:

• Compound identity
• Assay accuracy
• Purity confirmation
• Microbial safety
• Endotoxin levels
• Heavy metal screening
• Full batch traceability

All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.

Research Use Limitation

• Used solely for in vitro experiments
• Not permitted for clinical trials involving humans
• Not permitted for human or veterinary administration
• Not permitted for investigational human use

Independently verified by Liquilabs s.r.o. (Czechia)
Validated assay content 9.66 mg
Purity greater than 99.8 percent
Retention time and spectral identity confirmation
Endotoxin levels below 0.001 EU per mg
No detectable microbial contamination
No detectable heavy metals
For research use only — not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.